Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Total Debt (2020 - 2025)

Historic Total Debt for PROCEPT BioRobotics (PRCT) over the last 6 years, with Q3 2025 value amounting to $51.6 million.

  • PROCEPT BioRobotics' Total Debt fell 350.31% to $51.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $51.6 million, marking a year-over-year decrease of 350.31%. This contributed to the annual value of $53.5 million for FY2024, which is 46.41% up from last year.
  • As of Q3 2025, PROCEPT BioRobotics' Total Debt stood at $51.6 million, which was down 350.31% from $51.5 million recorded in Q2 2025.
  • PROCEPT BioRobotics' Total Debt's 5-year high stood at $53.5 million during Q1 2025, with a 5-year trough of $49.8 million in Q3 2021.
  • Its 5-year average for Total Debt is $51.7 million, with a median of $51.3 million in 2023.
  • Its Total Debt has fluctuated over the past 5 years, first soared by 415.34% in 2024, then tumbled by 350.31% in 2025.
  • PROCEPT BioRobotics' Total Debt (Quarter) stood at $50.0 million in 2021, then increased by 2.42% to $51.2 million in 2022, then rose by 3.93% to $53.2 million in 2023, then increased by 0.46% to $53.5 million in 2024, then decreased by 3.56% to $51.6 million in 2025.
  • Its Total Debt was $51.6 million in Q3 2025, compared to $51.5 million in Q2 2025 and $53.5 million in Q1 2025.